The week in health tech, explained in plain English.Get the free newsletter →
October 24, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Government

Trump Affordability Czar Sets Sights on Hospital Costs

The Trump administration's health care affordability czar is putting hospitals at the center of the cost debate, framing them as a major driver of high prices for American patients, according to STAT News. The czar is also backing cuts to Medicaid, signaling an aggressive posture toward spending in the federal health program.

The focus on hospitals reflects a growing bipartisan scrutiny of consolidation, facility fees, and opaque pricing that pushes up costs across the system. Pairing that pressure with Medicaid cuts, however, sets up a tension: providers that treat large numbers of low-income patients could face squeezed reimbursement at the same time they're being pressed to lower prices.

STAT News also reports that a federal alcohol study, previously buried, has now been published, and that there is a new update on the Biosecure Act, the measure aimed at restricting U.S. business with certain Chinese biotech companies. Together the items point to an administration willing to reshape health policy on multiple fronts.

Sources

More in Government

Government

FDA Approves First Once-Weekly Insulin for Children

The FDA approved Novo Nordisk's Awiqli, the first once-weekly basal insulin for children 10 and older with Type 2 diabetes.

Why it matters: Weekly rather than daily insulin could improve adherence for a growing number of children with Type 2 diabetes.

Government

Feds Launch False Claims Act Self-Disclosure Pilot

HHS and the DOJ Civil Division have launched a six-month pilot letting healthcare companies self-report potential civil False Claims Act violations and settle through a coordinated civil release.

Why it matters: The pilot reshapes how hospitals and healthcare firms weigh self-reporting against federal fraud enforcement, with real consequences for compliance strategy.

Government

GOP Pushes Fraud Message to Deflect Healthcare Cost Anger

Republicans are elevating healthcare fraud as a midterm message to deflect voter anger over costs, while Democrats say the push targets blue states to justify Medicaid and ACA cuts.

Why it matters: Fraud-focused enforcement could reshape Medicaid and ACA funding, audits, and eligibility for the tens of millions who depend on those programs.